有価証券レコード · アーカイブ済み四半期
JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
23追跡対象保有者
+3Δ保有者数
290.64M保有株数
$42.01B報告済み評価額
+3新規ポジション
−0解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり +15.0% ·
株式フロー -0.5% ·
新規ネットポジション数 +13.0%
— 計算式
保有の分散化 — 保有者数の増加、合計持分の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q4 2024
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.13B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
保有者情報 · Q4 2024
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (パッシブ) | 134.46M | — | $19.44B | 0.8% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (パッシブ) | 57.67M | +2.8% | $8.32B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (パッシブ) | 57.67M | +2.8% | $8.32B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 4 | Norges Bank ✦ (パッシブ) | 30.36M | +4.5% | $4.39B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 24.36M | +1.8% | $3.52B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 16.28M | -35.3% | $2.35B | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 16.28M | -35.3% | $2.35B | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 8.19M | +8.4% | $1.19B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 4.06M | -23.0% | $586.83M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 4.06M | -23.0% | $586.83M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 4.06M | -23.0% | $586.83M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 3.47M | +9.9% | $500.09M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 2.37M | +105.3% | $342.27M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 1.87M | +183.6% | $269.75M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 1.87M | +183.6% | $269.75M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 27 | Millennium Management ✦ | 1.75M | +2046.0% | $252.54M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 28 | Tweedy, Browne ✦ | 1.08M | -4.1% | $156.26M | 10.5% | ▼ Trim | 3 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 972.01K | +375.6% | $140.57M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 972.01K | +375.6% | $140.57M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 31 | Adage Capital Partners ✦ | 934.80K | -42.3% | $135.19M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 921.50K | 新規 | $133.27M | 0.2% | New | 1 | SEC ↗ |
| 33 | Markel Group ✦ | 610.80K | 0.0% | $88.33M | 0.8% | Held | 3 | SEC ↗ |
| 34 | Markel Group ✦ | 610.80K | 0.0% | $88.33M | 0.8% | Held | 3 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 537.94K | -63.4% | $77.80M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 36 | Point72 Asset Management ✦ | 305.73K | 新規 | $44.21M | 0.1% | New | 1 | SEC ↗ |
| 37 | Gotham Asset Management ✦ | 199.13K | -8.5% | $28.80M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 38 | GAMCO Investors ✦ | 92.93K | -3.8% | $13.44M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 39 | Fairfax Financial ✦ | 73.40K | 0.0% | $10.62M | 0.7% | Held | 3 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 63.77K | 新規 | $9.22M | 0.0% | New | 1 | SEC ↗ |
| 41 | Dodge & Cox ✦ | 21.10K | 0.0% | $3.05M | 0.0% | Held | 3 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| Renaissance Technologies | $133.27M | 0.2% |
| Point72 Asset Management | $44.21M | 0.1% |
| Two Sigma Investments | $9.22M | 0.0% |
ポジション解消済み
| 今四半期は追跡されたエグジットがありません。 |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 1 保有者, 136.10K 株式数, $33,268 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Aug 17
Taubert Jennifer L
Officer · 15.00K 株 · $3.95M
Aug 13
Duato Joaquin
Officer, Director · 20.98K 株 · $5.50M
Aug 13
Duato Joaquin
Officer, Director · 102.31K 株 · $26.70M
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
ニュース
Aug 24
US FDA expands approval for J&J's drug for rare blood disorder ↗
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a…
Reuters